The two companies reportedly could not agree on a price, leaving pharma’s first potential megadeal of 2026 on ice.

Guardant and MSD will evaluate opportunities to develop new oncology therapies using liquid biopsy tests.

That is according to the Wall Street Journal, which has said MSD failed to reach an agreement with Revolution on a fair price ...

MSD and the Coalition for Epidemic Preparedness Innovations have launched a $30 million initiative to improve the ...

Merck & Co (MSD) has taken the first of two possible plunges in its ongoing collaboration with Evaxion, gaining the rights to a mystery infectious disease vaccine candidate. The US big pharma decided ...

SK bioscience announced that it is advancing the development of a Zaire ebolavirus vaccine under a new collaboration ...

WASTE WATCHERS: Largely unheralded, the Buncombe County Metropolitan Sewerage District ensures that the waste generated by its approximately 130,000 customers is properly treated and disposed of ...